The assumption that dengue fever is a traveler's disease returnable from the tropics is quietly eroding. Southern Europe is undergoing a measurable epidemiological transition — from occasional imported cases to recurring local transmission — and the conditions enabling that shift are structural, not temporary.
The review synthesizes evidence from recent outbreaks in Italy, Spain, and France, attributing local transmission primarily to the established presence of Aedes albopictus (tiger mosquito), rising climatic suitability for vector breeding and viral replication, and increasing volumes of imported cases from endemic regions serving as ignition points. A compounding factor is diagnostic latency: in non-endemic settings, clinicians rarely consider dengue early in a febrile illness, allowing viremic individuals to remain in the community longer — a critical window during which local mosquitoes can acquire and transmit the virus. Population-level immunity to dengue serotypes in Europe remains near zero, meaning the susceptible pool is vast. The review also evaluates intervention tools, including the TAK-003 vaccine and Wolbachia-based vector suppression, noting their promise but contextual limitations in a European public health framework.
This analysis carries weight beyond dengue specifically. It represents a well-documented case study of how vector-borne diseases historically constrained to the tropics can gain footholds in temperate regions through the convergence of ecological and demographic pressures. From a longevity and healthspan perspective, dengue is not merely an acute febrile illness — severe dengue and post-dengue fatigue syndromes impose meaningful long-term physiological burdens. For health-conscious Europeans, particularly those in Mediterranean climates, this is a developing environmental health risk rather than a distant tropical concern. The review's reliance on modeling approaches is acknowledged as constrained by data scarcity in newly affected regions, and the epidemiological picture will sharpen considerably over the next five to ten transmission seasons. Incremental in scope, but genuinely signals a paradigm shift in European infectious disease geography.